MC-MMD10 consisting of MMD-10 conjugated to the MC linker, is an advanced drug-linker molecule that features a multifaceted functional group. This group enables precise conjugation, enhanced solubility, and controlled drug release, paving the way for improved therapeutic potential in the context of antibody-drug conjugates (ADCs).
Introduction to the application:
MC-MMD10 specifically in the design of ADCs for targeted cancer therapy. By employing the MMD-10 toxin conjugated to the MC linker, the complex allows for accurate delivery of the potent cytotoxic agent to cancer cells, thereby minimizing off-target effects and enhancing treatment efficacy. The unique characteristics of the MC linker ensure stability in the bloodstream and selective release within tumor cells, ultimately contributing to the development of safer and more effective anticancer treatments.
AxisPharm offers 5000+ PEG Linkers with high purity. Different kinds of PEG Reagents may be available by custom synthesis.
